BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create ADCs with improved internalization and trafficking. Our proprietary tech combines single-cell bioassay engineering, robotics, and ML. #synbio #directedevolution #antibodies #ADCs
| Website | http://www.bioloomics.com |
| Employees | 10 (10 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
PHP
+16 more
(view full list)
|
| Industry | Biotechnology Research, Discovery Tools (Healthcare) |
| Keywords | Antibody Drug Conjugates, Therapeutic Antibodies, Adc Technology, Directed Evolution, Cancer Therapeutics, Immunotherapy, Oncology Research, Protein Engineering, Single Cell Analysis, Precision Medicine, Biotechnology, Drug Development, Cell Line Engineering, Biopharmaceutical, Preclinical Development, Drug Discovery, Pharmaceutical Research, Robotics Automation |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, Cleveland Clinic, QIAGEN, Bionano Genomics, Inc., DNAnexus, Genospace, OncoDNA +40 more (view full list) |
Looking for a particular BioLoomics, Inc. employee's phone or email?
Doug Chapnick is the Founder of BioLoomics, Inc..
10 people are employed at BioLoomics, Inc..
BioLoomics, Inc. is based in Boulder, Colorado.